Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy

Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy

Different factors are used as predictors of unfavorable clinical outcomes in B-Cell Acute Lymphoblastic Leukemia (B-ALL) patients. However, new prognostic markers are needed in order to allow treatment to be more accurate, providing better results and an improved quality of life. In the present stud...

Full description

Bibliographic Details
Main Authors: Marlon Wendell Athaydes Kerr, Fábio Magalhães-Gama, Hiochelson Najibe Santos Ibiapina, Fabíola Silva Alves Hanna, Lilyane Amorim Xabregas, Eliana Brasil Alves, João Paulo Diniz Pimentel, Maria Perpétuo Socorro Sampaio Carvalho, Andréa Monteiro Tarragô, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Allyson Guimarães da Costa, Adriana Malheiro
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
leukemia
bone marrow microenvironment
chemokines
cytokines
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.696032/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.696032/full

Similar Items